Bristol Myers Sotyktu Approval Sends Ventyx Stock Soaring
Big Pharma Bristol Myers Squibb won approval for plaque psoriasis therapy Sotyktu on September 9th - the drug may have $4bn peak sales potential. Click to read.
Bristol Myers Sotyktu Approval Sends Ventyx Stock Soaring
Big Pharma Bristol Myers Squibb won approval for plaque psoriasis therapy Sotyktu on September 9th - the drug may have $4bn peak sales potential. Click to read.